机译:口腔悬浮液与延迟释放片剂配方的临床结果对侵袭性真菌感染的预防
Oregon Hlth &
Sci Univ Oregon State Univ Coll Pharm Dept Pharm Practice Portland OR 97201 USA;
Oregon Hlth &
Sci Univ Oregon State Univ Coll Pharm Dept Pharm Practice Portland OR 97201 USA;
Oregon Hlth &
Sci Univ Oregon State Univ Coll Pharm Dept Pharm Practice Portland OR 97201 USA;
Oregon Hlth &
Sci Univ Hosp &
Clin Dept Pharm Serv Portland OR 97201 USA;
VA Portland Healthcare Syst Div Infect Dis Portland OR USA;
Oregon Hlth &
Sci Univ Hosp &
Clin Dept Pharm Serv Portland OR 97201 USA;
Oregon Hlth &
Sci Univ Oregon State Univ Coll Pharm Dept Pharm Practice Portland OR 97201 USA;
Oregon Hlth &
Sci Univ Oregon State Univ Coll Pharm Dept Pharm Practice Portland OR 97201 USA;
Oregon Hlth &
Sci Univ Oregon State Univ Coll Pharm Dept Pharm Practice Portland OR 97201 USA;
Oregon Hlth &
Sci Univ Oregon State Univ Coll Pharm Dept Pharm Practice Portland OR 97201 USA;
antifungal agents; formulation; invasive fungal infection; medical outcomes; posaconazole; prophylaxis;
机译:口腔悬浮液与延迟释放片剂配方的临床结果对侵袭性真菌感染的预防
机译:预防侵袭性曲霉感染与止血剂恶性肿瘤患者的悬浮液和延迟释放片剂配方
机译:普沙康唑片和口服混悬液用于治疗和预防侵袭性真菌感染的血液癌症患者的泊沙康唑血清浓度比较
机译:甲硝唑低剂量双粘附盘的体内评价及其与口服片剂在牙周感染中的比较
机译:新型配方:开发针对虹鳟鱼中的传染性造血坏死病毒(IHNV)的口服微粒非病毒DNA疫苗输送系统,采用基质片剂配方进行统计设计。
机译:泊沙康唑口服混悬液与延迟释放片制剂预防真菌侵袭性的临床结果
机译:预防血吸虫止动和延迟释放片剂的侵袭性曲霉感染患者止血性恶性肿瘤患者